Alzheimer Disease/Dementia

Medicare’s Comprehensive Care for Joint Replacement model was found to be associated with a similar effect on joint replacement rates for beneficiaries with and without dementia.
Read More

The length of life after dementia diagnosis is found to differ among US racial and ethnic groups in a study of >670,000 patients.
Read More

A simple blood test could predict the progression of neurodegeneration and cognitive decline in patients with Alzheimer disease, even at early stages.
Read More

In patients with Alzheimer’s disease with clinically significant apathy, treatment with methylphenidate for 6 months in ADMET 2 was associated with a modest improvement in apathy.
Read More

A retrospective cohort study found that newly diagnosed depression increased the risk of Alzheimer’s disease in older individuals, especially when the depression was severe.
Read More

In patients with type 2 diabetes, a younger age of onset is associated with an increased risk of developing dementia.
Read More

According to the recent Study of Mirtazapine for Agitated Behaviors in Dementia (SYMBAD) trial, there was no improvement in agitation in patients with Alzheimer disease taking mirtazapine compared with placebo. Furthermore, the treatment group had more deaths than the placebo group, and the investigators suggested that mirtazapine should no longer be used for agitation in patients with dementia.
Read More

Researchers developed a model to predict when cognitively unimpaired individuals who have brain amyloidosis would develop symptoms of Alzheimer dementia using positron emission tomography scans for amyloid accumulation.
Read More

Discontinuation of pimavanserin for dementia-related psychosis was associated with a higher rate of relapse compared with continuation, according to a recent randomized discontinuation trial that was stopped early for efficacy.
Read More

Elderly women with cerebrovascular disease had a significantly increased risk for dementia if they took calcium supplements, a retrospective analysis of 2 studies showed.
Read More

Page 1 of 2

Subscribe to Value-Based Care in Neurology

Stay up to date with the latest news in neurology by subscribing to receive the free VBCN e‑Newsletter.